You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gene rearrangement

Showing 1 - 25 of 6,018
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

Not yet recruiting
  • Advanced Cholangiocarcinoma
  • +2 more
  • (no location specified)
Feb 3, 2023

Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement Trial in Rome (Diagnostic Test)

Recruiting
  • Genome Instability
  • +2 more
  • Diagnostic Test
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Aug 30, 2023

Healthy Volunteers Trial in Limoges (Blood sample)

Completed
  • Healthy Volunteers
  • Blood sample
  • Limoges, France
    Limoges University Hospital
Oct 18, 2021

Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

NSCLC, ALK Gene Rearrangement Positive Trial in United States (Ensartinib)

Available
  • Non-Small Cell Lung Cancer
  • ALK Gene Rearrangement Positive
  • Stanford, California
  • +3 more
Oct 18, 2022

Nsclc, EGFR Activating Mutation, EGF-R Positive NSCLC Trial in Hong Kong (Pembrolizumab, Lenvatinib, Pemetrexed)

Recruiting
  • Nsclc
  • +5 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 25, 2021

Radiotherapy Side Effect, NSCLC, ALK Gene Mutation Trial in Stockholm (SBRT/SRS/radiation therapy)

Not yet recruiting
  • Radiotherapy Side Effect
  • +2 more
  • SBRT/SRS/radiation therapy
  • Stockholm, Sweden
    Karolinska University Hospital
Feb 16, 2023

Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

Recruiting
  • Solid Tumor
  • +4 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 28, 2023

NSCLC, Crizotinib, ALK Gene Rearrangement or ROS1 Gene Rearrangement Trial in France

Completed
  • NSCLC
  • +2 more
    • Aix en Provence, France
    • +25 more
    Sep 24, 2021

    Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

    Recruiting
    • Relapsed/Refractory Leukemias
    • +4 more
    • Kansas City, Missouri
    • +1 more
    Jul 18, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)

    Not yet recruiting
    • High-grade B-cell Lymphoma
    • +8 more
    • Sepantronium Bromide
    • Busan, Korea, Republic of
    • +5 more
    Feb 27, 2022

    NSCLC Stage IIIB, NSCLC Stage IV, EGFR Gene Mutation Trial in France (Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab,

    Recruiting
    • NSCLC Stage IIIB
    • +4 more
    • Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab
    • Carboplatin + Pemetrexed + Atezolizumab
    • Angers, France
    • +30 more
    Jun 7, 2021

    BRCA Gene Rearrangement Trial in Seoul (BRCA 1, Chemotherapy)

    Completed
    • BRCA Gene Rearrangement
    • Seoul, Korea, Republic of
      Chung-Ang University College of Medicine
    Jan 25, 2021

    ALK Gene Rearrangement Positive, Non-Squamous Non-Small Cell Tumor of Lung Trial in Mexico City (Alectinib, Bevacizumab)

    Unknown status
    • ALK Gene Rearrangement Positive
    • Non-Squamous Non-Small Cell Neoplasm of Lung
    • Mexico City, Mexico
      Instituto Nacional de Cancerologia
    Feb 8, 2021

    Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

    Not yet recruiting
    • Acute Myeloid Leukemia With KMT2A Rearrangement
    • Acute Myeloid Leukemia With NPM1 Mutation
    • Biospecimen Collection
    • +7 more
    • (no location specified)
    Jun 1, 2023

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    Lung Cancer, ROS1 Gene Rearrangement Trial in Shanghai (X-396 Capsule)

    Unknown status
    • Lung Cancer
    • ROS1 Gene Rearrangement
    • X-396 Capsule
    • Shanghai, Shanghai, China
      Chest hospital affiliated to Shanghai jiao tong university
    Jan 6, 2020

    Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

    Recruiting
    • Cancer, Metastatic
    • +42 more
    • Clinical Trial Matching
    • New York, New York
      Massive Bio, Inc
    May 21, 2021

    ALK Gene Rearrangement, EGFR Gene Mutation, Locally Advanced Lung Non-Small Cell Carcinoma Trial in Houston (Ipilimumab,

    Recruiting
    • ALK Gene Rearrangement
    • +11 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2020

    Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

    Recruiting
    • Lung Cancer
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Mar 7, 2021

    NSCLC, ALK Gene Rearrangement Positive Trial in France (RNAseq)

    Recruiting
    • Non-small Cell Lung Cancer
    • ALK Gene Rearrangement Positive
    • RNAseq
    • Saint-Denis, La Réunion, France
    • +44 more
    Nov 4, 2021

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Atlanta, Georgia
    • +3 more
    Jan 6, 2023

    Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Los Angeles (Autologous

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
    • Pembrolizumab
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jul 21, 2022

    Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (EPZ-5676)

    Completed
    • Leukemia
    • +3 more
    • Los Angeles, California
    • +8 more
    May 7, 2020